VSTMVerastem, Inc.

$376M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$556,000

Operating Income

-$68M

Net Income

-$68M

EPS (Diluted)

$-21.18

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$90M

Total Liabilities

$32M

Stockholders' Equity

$58M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$556,000	-$670,000	+17.0%
Operating Income	-$68M	-$37M	-83.2%
Net Income	-$68M	-$36M	-86.1%

VSTM FY 2017 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena